Corvus Pharmaceuticals, Inc. Business Finance Contracts & Agreements
9 Contracts & Agreements
- Exchange Agreements (1 contract)
- Investor Rights Agreements (1)
- Purchase Agreements (1)
- Underwriting Agreements (3)
- Warrant Agreements (3)
- Securities Purchase Agreement, dated May 1, 2024, between the Company and the Investors (Filed With SEC on May 6, 2024)
- Form of Common Warrant (Filed With SEC on May 6, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on May 6, 2024)
- Underwriting Agreement, dated as of February 12, 2021, among Corvus Pharmaceuticals, Inc. and Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC as the underwriters (Filed With SEC on February 17, 2021)
- Exchange Agreement, dated November 8, 2019, by and among, Corvus Pharmaceuticals, Inc., Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value... (Filed With SEC on November 12, 2019)
- Form of Warrant (Filed With SEC on November 12, 2019)
- Underwriting Agreement, dated as of March 8, 2018, among Corvus Pharmaceuticals, Inc. and Credit Suisse Securities (USA) LLC and Jefferies LLC, as representatives of the... (Filed With SEC on March 21, 2018)
- CORVUS PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on February 8, 2016)
- Corvus Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on February 8, 2016)
